throbber
Trials@uspto.gov
`Tel: 571-272-7822
`
`
`Paper No. 128
`Entered: February 23, 2018
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_______________
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_______________
`MYLAN PHARMACEUTICALS INC., TEVA PHARMACEUTICALS
`USA, INC., and AKORN INC.
`Petitioners,
`
`v.
`
`SAINT REGIS MOHAWK TRIBE and ALLERGAN, INC.,
`Patent Owners.
`____________
`
`Case IPR2016-01127 (8,685,930 B2); Case IPR2016-01128 (8,629,111 B2);
`Case IPR2016-01129 (8,642,556 B2); Case IPR2016-01130 (8,633,162 B2);
`Case IPR2016-01131 (8,648,048 B2); Case IPR2016-01132 (9,248,191 B2)
`1
`_______________
`
`Before SHERIDAN K. SNEDDEN, TINA E. HULSE, and
`CHRISTOPHER G. PAULRAJ, Administrative Patent Judges.
`
`PAULRAJ, Administrative Patent Judge.
`
`
`ORDER
`Conduct of the Proceedings
`37 C.F.R. § 42.5
`
`
`
`1 Cases IPR2017-00576 and IPR2017-00594, IPR2017-00578 and IPR2017-
`00596, IPR2017-00579 and IPR2017-00598, IPR2017-00583 and IPR2017-
`00599, IPR2017-00585 and IPR2017-00600, and IPR2017-00586 and
`IPR2017-00601, have respectively been joined with the captioned
`proceedings. This Order addresses issues that are the same in the identified
`cases. Paper numbers and exhibits cited in this Order refer to those
`documents filed in IPR2016-01127.
`
`

`

`IPR2016-01127 (8,685,930 B2); IPR2016-01128 (8,629,111 B2);
`IPR2016-01129 (8,642,556 B2); IPR2016-01130 (8,633,162 B2);
`IPR2016-01131 (8,648,048 B2); IPR2016-01132 (9,248,191 B2)
`
`
`Allergan’s Motion to Withdraw
`Pursuant to our authorization, Allergan, Inc. (“Allergan”) filed a
`motion to withdraw from these proceedings. Paper 126 (“Motion” or
`“Mot.”). Petitioners filed an opposition to Allergan’s Motion. Paper 128
`(“Opposition” or “Opp’n”).
`Allergan seeks to withdraw from these proceedings on the grounds
`that it has ceased to be an owner of the six patents involved in these
`proceedings in view of its agreements with the Saint Regis Mohawk Tribe
`(“the Tribe”). Mot. 4–5. Petitioners contend that the “ownership question,
`however, is a fundamental dispute that has been extensively briefed in
`connection with the Tribe’s pending Motion to Dismiss.” Opp’n 1.
`Petitioners further contend that Allergan is at least a joint owner as a result
`of the agreements with the Tribe, and that Allergan has already taken all
`actions authorized to be taken by the patent owner under our rules and
`governing statute. Id. at 2–3. Additionally, Petitioners contend that
`Allergan’s request to withdraw should be construed as an abandonment of
`these proceedings, and thus a request for adverse judgement under 37 C.F.R.
`§ 42.73(b)(4). Id. at 4–5.
`As set forth in our Decision Denying the Tribe’s Motion to Terminate,
`we determine that Allergan remains an effective “patent owner” of the
`challenged patents in these proceedings based on the terms of its License
`Agreement with the Tribe. Paper __, 18–34. Accordingly, we find that the
`basis for Allergan’s request to withdraw does not hold true. We decline,
`however, to construe the request to withdraw as a request for adverse
`judgment insofar as the ownership question was not settled at the time
`
` 2
`
`
`
`
`
`

`

`IPR2016-01127 (8,685,930 B2); IPR2016-01128 (8,629,111 B2);
`IPR2016-01129 (8,642,556 B2); IPR2016-01130 (8,633,162 B2);
`IPR2016-01131 (8,648,048 B2); IPR2016-01132 (9,248,191 B2)
`
`Allergan filed its Motion. In this regard, we recognize that the Tribe may
`still claim an ownership interest in the challenged patents in a subsequent
`appeal to the Federal Circuit. In order to allow the Tribe to represent its
`interests in these proceedings before the Board and in any appeals, we will
`allow the Tribe to continue participating as a patent owner along with
`Allergan. Allergan and the Tribe shall coordinate their efforts going
`forward, and shall file joint papers in these proceedings unless otherwise
`authorized by the Board. The caption for this Order and subsequent orders
`and decisions in these proceedings will reflect both Allergan’s and the
`Tribe’s status as the named “Patent Owners.”
`Remaining Schedule
`In view of our Decision Denying the Tribe’s Motion to Terminate, we
`will resume the schedule for these proceedings and proceed to a final written
`decision. The parties had previously submitted requests for oral hearing
`pursuant to 37 C.F.R. § 42.70(a). Papers 47 and 48. Accordingly, an oral
`hearing has been tentatively scheduled for April 3, 2018. Within five (5)
`business days after entry of this Order, the parties shall meet and confer and
`notify the Board via email whether this hearing date is acceptable to the
`parties or, if not, the parties shall provide the Board with several mutually
`acceptable dates for a hearing. Any proposed hearing dates shall be no later
`than April 6, 2018. We will consider the proposed hearing dates and enter a
`revised Hearing Order with the new date for the hearing, subject to the
`availability of hearing rooms at the Board.
`
` 3
`
`
`
`
`
`

`

`IPR2016-01127 (8,685,930 B2); IPR2016-01128 (8,629,111 B2);
`IPR2016-01129 (8,642,556 B2); IPR2016-01130 (8,633,162 B2);
`IPR2016-01131 (8,648,048 B2); IPR2016-01132 (9,248,191 B2)
`
`
`In order to provide ourselves with sufficient time to consider the
`arguments presented, we will also adjust the time to enter our final written
`decisions in these proceedings to June 6, 2018.
`ORDER
`Accordingly, based on the foregoing, it is:
`ORDERED that Allergan’s Motion to Withdraw is denied;
`FURTHER ORDERED that the Tribe may continue participating as a
`patent owner along with Allergan. Allergan and the Tribe shall coordinate
`their efforts going forward, and shall file joint papers in these proceedings
`unless otherwise authorized by the Board. The caption for these proceedings
`shall reflect both Allergan’s and the Tribe’s status as “Patent Owners”;
`FURTHER ORDERED that an oral hearing has been tentatively
`scheduled for April 3, 2018;
`FURTHER ORDERED that within five (5) business days after entry
`of this Order, the parties shall meet and confer and notify the Board via
`email whether April 3, 2018, is acceptable to the parties for a hearing, or, if
`not, the parties shall provide the Board with several mutually acceptable
`dates for a hearing no later than April 6, 2018; and
`FURTHER ORDERED that the time to enter final written decisions in
`these proceedings is adjusted to June 6, 2018.
`
`
`
` 4
`
`
`
`
`
`

`

`IPR2016-01127 (8,685,930 B2); IPR2016-01128 (8,629,111 B2);
`IPR2016-01129 (8,642,556 B2); IPR2016-01130 (8,633,162 B2);
`IPR2016-01131 (8,648,048 B2); IPR2016-01132 (9,248,191 B2)
`
`PETITIONER MYLAN:
`
`Steven W. Parmelee
`Michael T. Rosato
`Jad A. Mills
`WILSON SONSINI GOODRICH & ROSATI
`sparmelee@wsgr.com
`mrosato@wsgr.com
`jmills@wsgr.com
`
`PETITIONER TEVA:
`
`Gary Speier
`Mark Schuman
`CARLSON, CASPERS, VANDENBURH,
` LINDQUIST & SCHUMAN, P.A.
`gspeier@carlsoncaspers.com
`mschuman@carlsoncaspers.com
`
`PETITIONER AKORN:
`
`Michael Dzwonczyk
`Azadeh Kokabi
`Travis Ribar
`SUGHRUE MION, PLLC
`mdzwonczyk@sughrue.com
`akokabi@sughrue.com
`
`
`PATENT OWNER:
`
`Dorothy P. Whelan
`Michael Kane
`Susan Coletti
`Robert Oakes
`FISH & RICHARDSON P.C.
`whelan@fr.com
`PTABInbound@fr.com
`
` 5
`
`
`
`
`
`

`

`IPR2016-01127 (8,685,930 B2); IPR2016-01128 (8,629,111 B2);
`IPR2016-01129 (8,642,556 B2); IPR2016-01130 (8,633,162 B2);
`IPR2016-01131 (8,648,048 B2); IPR2016-01132 (9,248,191 B2)
`
`coletti@fr.com
`oakes@fr.com
`
`Alfonso Chan
`Michael Shore
`Christopher Evans
`SHORE CHAN DEPUMPO LLP
`achan@shorechan.com
`mshore@shorechan.com
`cevans@shorechan.com
`
`Marsha Schmidt
`marsha@mkschmidtlaw.com
`
`
`
` 6
`
`
`
`
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket